Dr. Chu raises several important issues regarding the diagnosis of
toxin-induced parkinsonism. To address his specific questions:
1. As stated in table 1 the mean years of exposure in these patients
was 25.2 years. More specific exposure data was not presented in detail in
our paper, as this was a pharmacological study. Most of the patients were
no longer working therefore measuring manganese in the blood or urine or
obtaining an MRI scan would be of no value. We agree that neuroimaging of
the dopamine system would most likely be helpful in the differential
diagnosis. However there is minimal data for neuroimaging in manganese
intoxication and what exactly there studies would tell us is uncertain.
However if a fluorodopa PET scan is normal the diagnosis of Parkinson’s
disease would be unlikely.
2. We also believe that this is a broad spectrum of clinical
phenotypes for the various forms of parkinsonism. Regarding our paper we
feel confidently that one of the authors (WCK) can recognize parkinsonism.
The diagnosis of manganese induced parkinsonism was a presumptive one, as
stated, for the purpose of the study. We used the term parkinsonism in
welders as a descriptive term. We also acknowledged the diagnostic
uncertainty in these patients
3. We agree the diagnosis of different types of parkinsonism may be
difficult. There are few biomarkers that are useful in this regard. This
is in fact why we did this study to see if levodopa responsiveness can be
useful in separating various forms of parkinsonism, which if fact it
appears to be, as Dr. Chu has reported previously.1
4. Lastly a case of parkinsonism due to manganese in a welder has
been reported which addresses many of the diagnostic concerns of Dr. Chu
.2
Finally we agree that more scientific investigation is necessary
regarding toxins that cause parkinsonism.
References
1.Lu, CS, Huang, CC, Chu, NS, Calne, DB. Levodopa failure in chronic
manganism. Neurology 1994; 44:1600-1622
2.Sadek, AH, Rauch, R, Schulz, PE. Parkinsonism due to manganism in
a welder. Int. J. Tox 2003; 22:393-401
William C. Koller, MD, Ph.D
Kelly E. Lyons, Ph.D.